TRIO 016

• Research type

  Research Study

• Full title

  A randomized phase II, open label multicenter trial of panobinostat (LBH589) monotherapy in women with HER2 positive locally recurrent or metastatic breast cancer

• IRAS ID

  11662

• Sponsor organisation

  Cancer International Research Group

• Eudract number

  2008-003175-45

• Clinicaltrials.gov Identifier

  NCT00777335

• Research summary

  The aim of the study is to assess the benefit of panobinostat monotherapy given either orally or i.v. to women with HER2-positive locally recurrent or metastatic breast cancer

• REC name

  East Midlands - Nottingham 2 Research Ethics Committee

• REC reference

  09/H0408/59

• Date of REC Opinion

  5 Jun 2009

• REC opinion

  Further Information Favourable Opinion